Enteric microorganism detection method based on short-chain fatty acid correlation analysis
By measuring the content of short-chain fatty acids in the blood and constructing a correlation formula, the sampling difficulties and high cost of intestinal microbial detection in the prior art are solved, and a fast and accurate judgment of intestinal microbial status is achieved.
Patent Information
- Application Number
- CN202411120130.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-15
- Publication Date
- 2024-11-19
AI Technical Summary
The existing intestinal microbial detection methods mainly rely on fecal samples, which have problems such as difficulty in sampling, poor sample quality and high cost, and lack of correlation analysis methods that combine short-chain fatty acids with intestinal microorganisms.
By measuring the content of short-chain fatty acids in the blood, constructing a correlation standard curve and fitting formula, calculating the relative abundance of intestinal microorganisms, and then inferring the status of intestinal microorganisms, providing a method for intestinal microorganism detection based on blood detection.
It realizes fast and accurate intestinal microbial detection, reduces detection cost and time, overcomes the problem of difficulty in feces sampling, and provides a comprehensive judgment of intestinal microbial status.
Smart Images

Figure CN118980764A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to an intestinal microorganism detection method based on correlation analysis of short-chain fatty acids in blood, which mainly estimates the relative abundance of intestinal microorganisms in the body by establishing a correlation relationship with the content of short-chain fatty acids in blood, and belongs to the field of biological detection. Background Art
[0002] The gastrointestinal tract is one of the four micro-ecosystems of the human body. It contains most of the microorganisms in the human body, accounting for about 78% of the total number of microorganisms in the human body. The total number of bacteria colonized in the human intestine is 10 to 20 times the total number of human cells. Therefore, the intestinal bacteria of the human body cannot be ignored. These intestinal flora affect the intestinal health of the human body through interaction and self-metabolism. The intestinal flora can help the human body complete metabolic processes that the human body cannot complete, such as metabolizing dietary fiber that the human body cannot metabolize, to provide the human body with essential nutrients. Normal and healthy intestinal flora can improve the body's resistance, and also have anti-aging, immune, detoxification, and anti-tumor effects. Many common chronic diseases of the human body, such as obesity, inflammatory bowel disease, depression, etc., are closely related to intestinal microorganisms. Therefore, detecting and monitoring the status of intestinal microorganisms can effectively prevent related diseases.
[0003] At present, the detection and monitoring of intestinal microorganisms are mostly carried out through 16s DNA sequencing of human fecal samples, which requires the sampler, tester and the tested person to bear great psychological pressure. At the same time, this sampling method also has problems such as difficulty in fecal sampling, difficulty in grasping the sampling timing, and poor sample quality.
[0004] Short-chain fatty acids (SCFAs) Short-chain fatty acids refer to fatty acids with less than 6 carbon atoms on the carbon chain and are volatile. Common short-chain fatty acids include acetic acid, propionic acid, butyric acid, isobutyric acid, valeric acid, isovaleric acid, and caproic acid. Short-chain fatty acids are products of intestinal microbial fermentation, and the main production site is the human colon. Although short-chain fatty acids cannot be used as a direct nutritional source for the human body, they can regulate certain physiological activities of the human body, regulate the body's electrolyte balance, protect the intestinal mucosal barrier, participate in lipid metabolism, and regulate intestinal pH. They play an important role in human health and intestinal microecology. There is also a close connection between short-chain fatty acids and common human diseases. Short-chain fatty acids can also slow the development of diabetes and have a protective effect in immune pancreatitis. Short-chain fatty acids such as propionic acid can increase the number of intestinal-related regulatory T cells, inhibit inflammation, and improve immunity. Sodium butyrate and sodium propionate produced by intestinal flora are negatively correlated with the function of the renin-angiotensin system mediated by renin receptors, and help lower blood pressure.
[0005] Intestinal flora and short-chain fatty acids influence each other. On the one hand, short-chain fatty acids are important products of intestinal microorganisms. For example, acetate is a metabolite produced by the fermentation of undigested carbohydrates in the small intestine by most anaerobic bacteria in the colon, and is the main substrate for cholesterol synthesis. The bacteria that produce short-chain fatty acids in the intestine are mainly anaerobic bacteria such as Bifidobacterium, Bacteroidetes, and Firmicutes. The type and number of intestinal microorganisms are important factors affecting the production of short-chain fatty acids. On the other hand, short-chain fatty acids can make the human intestine weakly acidic, improve intestinal flora imbalance, promote beneficial bacteria, and limit harmful bacteria.
[0006] The bacteria in the intestine are important factors affecting the intestinal microecology. These bacteria influence and restrict each other throughout the intestine. The relationships between these bacteria mainly include mutualism, commensalism, parasitism, predation, partial commensalism and competition. The interactions will have positive, negative and neutral effects on the participants. Various influences are intertwined to form a complex co-occurrence network. Therefore, in the intestinal microecology, bacteria that account for a relatively large proportion will promote the growth of bacteria that have a positive effect on them and inhibit the growth of bacteria that have a negative effect on them.
[0007] Correlation analysis refers to the analysis of two or more correlated variable elements to measure the degree of correlation between the two variable factors. There needs to be a certain connection or probability between the correlated elements in order to conduct correlation analysis. At present, short-chain fatty acids and intestinal microorganisms are only tested separately, which is costly, and few researchers combine the two. At the same time, the current tests on intestinal microorganisms are all based on a single sequencing analysis of the content of multiple bacteria, and there are few methods to infer the relative abundance of one or two bacteria from the relative abundance of another bacteria. Summary of the invention
[0008] In view of the deficiencies of the prior art, the present invention provides an intestinal microorganism detection method based on the correlation analysis of short-chain fatty acids in the blood. The purpose is to reduce the diagnostic cost and provide another detection method for people who are inconvenient to provide stool samples for intestinal microorganism detection. The present invention performs a correlation analysis on the short-chain fatty acids and intestinal microorganisms that affect each other, calculates the correlation coefficient, and simultaneously fits the short-chain fatty acids with strong correlation to the intestinal microorganism abundance to obtain a fitting formula; the relative abundance of intestinal microorganisms with strong correlation is fitted and analyzed to obtain a fitting formula, which can quickly and accurately determine the intestinal microbial status related to the short-chain fatty acids through the short-chain fatty acid content in the blood, and then derive the status of other common intestinal microorganisms from the intestinal microbial status, so as to have an overall and comprehensive judgment on the intestinal microorganisms.
[0009] The technical solution of the present invention is as follows:
[0010] A method for detecting intestinal microorganisms based on correlation analysis of short-chain fatty acids in blood, comprising the following steps:
[0011] S1: construct a standard curve of short-chain fatty acids;
[0012] S2: Based on the short-chain fatty acid standard curve constructed in S1, the LC-MS / MS method was used to determine and calculate the content of short-chain fatty acids in the blood sample;
[0013] S3: Based on the short-chain fatty acid content in the blood sample measured in S2, the relative abundance of the first batch of intestinal microorganisms was calculated using a fitting formula;
[0014] S4: Based on the relative abundance of the first batch of intestinal microorganisms obtained in S3, the relative abundance of the second batch of intestinal microorganisms is calculated using a fitting formula.
[0015] Preferably according to the present invention, in S1, the short-chain fatty acids are acetic acid, propionic acid, butyric acid, valeric acid and caproic acid.
[0016] Preferably according to the present invention, in S1, the short-chain fatty acid standard curve is:
[0017] Acetic acid: y = 8939.40456x + 7.08221e5;
[0018] Propionic acid: y = 6.54585e4x + 4.71269e5;
[0019] Butyric acid: y = 6.80889e4x + 2.45674e5;
[0020] Valeric acid: y = 57122.89199x + 6.683e4;
[0021] Hexanoic acid: y = 4.29983e4x + 1.75965e5;
[0022] Where y is the peak area and x is the concentration of short-chain fatty acids (μg / L).
[0023] Preferably according to the present invention, in S3, the first batch of intestinal microorganisms are Lactobacillus, Bacteroides, Bacillus, Bifidobacterium, Clostridium, and Enterobacter.
[0024] Preferably, according to the present invention, in S3, the fitting formula is as follows:
[0025] The fitting formula for acetic acid and Bifidobacterium is: y = 0.06650x + 0.00014;
[0026] The fitting formula for propionic acid and Enterobacter is: y = 0.00103x + 0.00009;
[0027] The fitting formula of propionic acid and Bacillus is: y = 0.007055x + 0.00593;
[0028] The fitting formula for butyric acid and Lactobacillus is: y = 0.001952x + 0.00624;
[0029] The fitting formula for valeric acid and Bacteroides is: y = 0.002554x + 0.002124;
[0030] The fitting formula for hexanoic acid and Clostridium is: y = 0.02271x + 0.00009;
[0031] Among them, y is the relative abundance of the first batch of intestinal microorganisms at the genus level, and x is the content of short-chain fatty acids in the blood (mg / L).
[0032] Preferably according to the present invention, in S4, the second batch of intestinal microorganisms are Prevotella, Lactococcus and Eubacterium.
[0033] Preferably, according to the present invention, in S4, the fitting formula is as follows:
[0034] The fitting formula for Prevotella and Bifidobacterium is: y = 0.62296x + 0.00001;
[0035] The fitting formula for Eubacterium and Bifidobacterium is: y = 0.83341x + 0.00003;
[0036] The fitting formula for Lactococcus and Lactobacillus is: y = 0.62296x + 0.00001;
[0037] Among them, y is the relative abundance of the second batch of intestinal microorganisms at the genus level, and x is the relative abundance of the first batch of intestinal microorganisms at the genus level.
[0038] According to a preferred technical solution of the present invention, the intestinal microorganism detection method based on the correlation analysis of short-chain fatty acids in the blood has the following specific steps:
[0039] (1) Accurately weigh 0.001 mg of each standard of acetic acid, propionic acid, butyric acid, valeric acid, and caproic acid into a 10 ml volumetric flask, and dissolve them in 50% acetonitrile solution to prepare a mixed short-chain fatty acid standard solution with a concentration of 1 mg / L for each short-chain fatty acid;
[0040] (2) adding the mixed short-chain fatty acid standard solution prepared in step (1) to 2 ml of blank plasma to obtain a mixed standard solution with gradient concentrations; the gradient concentrations are 500 μg / L, 250 μg / L, 150 μg / L, 100 μg / L, 50 μg / L, 20 μg / L, 10 μg / L, 5 μg / L, 2.5 μg / L, 1 μg / L, 0.5 μg / L, 0.25 μg / L, and 0.1 μg / L;
[0041] (3) Accurately weigh 0.948 g of 3-nitrophenylhydrazine hydrochloride and 0.5751 g of 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride, and dilute to 25 ml with 50% acetonitrile aqueous solution to prepare 200 mmol / L 3-nitrophenylhydrazine hydrochloride solution (3-NPH) and 120 mmol / L 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride solution (EDC);
[0042] (4) Add 0.5 ml of analytical grade acetonitrile solution to 1 ml of the mixed standard solution with gradient concentrations in step (2), centrifuge at 10,000 x g for 5 min, and collect the purified supernatant;
[0043] (5) Add 20 μl of 3-nitrophenylhydrazine hydrochloride solution and 20 μl of 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride solution to 20 μl of the supernatant obtained in step (4), shake for 2 min, and place in a 50°C water bath for 30 min to obtain a gradient concentration mixed standard solution after derivatization as a sample;
[0044] (6) injecting the gradient concentration mixed standard solution obtained in step (5) into a high performance liquid chromatography-tandem mass spectrometer for detection, using the sample concentration as the horizontal axis and the peak area as the vertical axis to construct a short-chain fatty acid standard curve;
[0045] The conditions of the HPLC are as follows:
[0046] Chromatographic column: Waters BEH C18 liquid phase column 100mm×2.1mm×1.7μm; column temperature 40℃, flow rate 30μl / min, acquisition time 10min, injection volume 5μl; mobile phase A is water; mobile phase B is acetonitrile;
[0047] Gradient elution program:
[0048]
[0049] The mass spectrometry source parameters of the tandem mass spectrometer are as follows: monitoring mode: MRM, GS1: 43 psi; GS2: 48 psi, curtain gas: 30 psi, collision gas: 7 psi, ion spray voltage: 5500 V, focusing voltage: 22 V, temperature: 233° C.;
[0050] The short-chain fatty acid standard curve is:
[0051] Acetic acid: y = 8939.40456x + 7.08221e5;
[0052] Propionic acid: y = 6.54585e4x + 4.71269e5;
[0053] Butyric acid: y = 6.80889e4x + 2.45674e5;
[0054] Valeric acid: y = 57122.89199x + 6.683e4;
[0055] Hexanoic acid: y = 4.29983e4x + 1.75965e5;
[0056] Where y is the peak area, x is the short-chain fatty acid content (μg / L);
[0057] (7) collecting blood from the test subject, purifying and derivatizing the blood according to steps (4) to (5), and injecting the blood into a high performance liquid chromatography-tandem mass spectrometer for detection, and calculating the contents of acetic acid, propionic acid, butyric acid, valeric acid, and caproic acid in the blood sample according to the short-chain fatty acid standard curve constructed in step (6);
[0058] (8) Calculating the relative abundance of the first batch of intestinal microorganisms using a fitting formula based on the contents of acetic acid, propionic acid, butyric acid, valeric acid, and caproic acid determined in step (7);
[0059] The fitting formula is as follows:
[0060] The fitting formula for acetic acid and Bifidobacterium is: y = 0.06650x + 0.00014;
[0061] The fitting formula for propionic acid and Enterobacter is: y = 0.00103x + 0.00009;
[0062] The fitting formula of propionic acid and Bacillus is: y = 0.007055x + 0.00593;
[0063] The fitting formula for butyric acid and Lactobacillus is: y = 0.001952x + 0.00624;
[0064] The fitting formula for valeric acid and Bacteroides is: y = 0.002554x + 0.002124;
[0065] The fitting formula for hexanoic acid and Clostridium is: y = 0.02271x + 0.00009;
[0066] Among them, y is the relative abundance of the first batch of intestinal microorganisms at the genus level, and x is the content of short-chain fatty acids in the blood (mg / L);
[0067] (9) Calculating the relative abundance of the second batch of intestinal microorganisms using a fitting formula based on the relative abundance of the first batch of intestinal microorganisms calculated in step (8);
[0068] The fitting formula is as follows:
[0069] The fitting formula for Prevotella and Bifidobacterium is: y = 0.62296x + 0.00001;
[0070] The fitting formula for Eubacterium and Bifidobacterium is: y = 0.83341x + 0.00003;
[0071] The fitting formula for Lactococcus and Lactobacillus is: y = 0.62296x + 0.00001;
[0072] Among them, y is the relative abundance of the second batch of intestinal microorganisms at the genus level, and x is the relative abundance of the first batch of intestinal microorganisms at the genus level.
[0073] The beneficial effects of the present invention are:
[0074] The present invention performs a correlation analysis between the short-chain fatty acid content in the blood and the intestinal microorganisms and a correlation analysis between the relative abundance of each microorganism in the intestinal tract based on the second-generation high-throughput sequencing results of 1000 children's intestinal microorganisms and the mass spectrometry detection results of the short-chain fatty acid content in the blood, and obtains a fitting formula for the correlation between the short-chain fatty acid content in the blood and the intestinal microorganisms and a fitting formula between the intestinal microorganisms, and then calculates the abundance of Lactobacillus, Bacteroides, Bacillus, Bifidobacterium, Clostridium, and Enterobacter in the intestinal tract according to the fitting formula between the intestinal microorganisms and the short-chain fatty acids according to the content of acetic acid, propionic acid, butyric acid, valeric acid, and caproic acid in the blood. At the same time, based on the relative abundance of the above-mentioned intestinal microorganisms and with reference to the fitting formula between the intestinal microorganisms, the relative abundance of other microorganisms in the intestinal tract is calculated.
[0075] The intestinal microorganism detection method based on the correlation analysis of short-chain fatty acids in blood provided by the present invention is simple and rapid, and does not require fecal sampling. Only by taking a blood sample, the detection of the relative abundance of short-chain fatty acids in the blood and common microorganisms in the intestine can be achieved, which solves the problems of sampling difficulties and detection difficulties when detecting intestinal microorganisms, saves time and economic costs, and can not only obtain intestinal microorganisms related to short-chain fatty acids, but also obtain other microorganisms that play an important role in the intestine, and conduct a more comprehensive detection of the intestinal microbial state. It can be widely used in various situations where short-chain fatty acids and intestinal microorganisms need to be quickly detected, and effectively overcomes the problems of fecal sampling difficulties, sampling timing difficulties, poor sample quality, etc. in the prior art. BRIEF DESCRIPTION OF THE DRAWINGS
[0076] Figure 1 It is a flow chart for determining the correlation between short-chain fatty acids and intestinal microorganisms. DETAILED DESCRIPTION
[0077] The present invention is further described below by means of specific examples, but is not limited thereto.
[0078] Instrument: AB Sciex 4500 triple quadrupole liquid spectrometer.
[0079] The human plasma blank matrix used in the present invention is obtained as follows: 4% bovine serum albumin solution (dissolved in physiological saline).
[0080] Example 1: Determination of the fitting formula for short-chain fatty acids and intestinal microorganisms
[0081] 1. Acquisition of short-chain fatty acid content data in blood
[0082] (1) Construction of short-chain fatty acid standard curve
[0083] ① Accurately weigh 0.001 mg of each standard of acetic acid, propionic acid, butyric acid, valeric acid, and caproic acid into a 10 ml volumetric flask, and dissolve them in 50% acetonitrile solution to prepare a mixed short-chain fatty acid standard solution with a concentration of 1 mg / L for each short-chain fatty acid;
[0084] ②, add the mixed short-chain fatty acid standard solution prepared in step ① to 2 ml of human plasma blank matrix to obtain a mixed standard solution with gradient concentrations; the gradient concentrations are 500 μg / L, 250 μg / L, 150 μg / L, 100 μg / L, 50 μg / L, 20 μg / L, 10 μg / L, 5 μg / L, 2.5 μg / L, 1 μg / L, 0.5 μg / L, 0.25 μg / L, 0.1 μg / L;
[0085] ③. Accurately weigh 0.948 g of 3-nitrophenylhydrazine hydrochloride (3-NPH) and 0.5751 g of 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride (EDC), and dilute to 25 ml with 50% acetonitrile aqueous solution to prepare 200 mmol / L 3-NPH solution and 120 mmol / L EDC solution;
[0086] ④. Collect the mixed standard solution of gradient concentrations obtained in ②, 1 ml of each concentration, add 0.5 ml of analytical pure acetonitrile solution, centrifuge at 10000xg for 5 min to remove protein, and take the purified supernatant;
[0087] ⑤. Add 20 μl of 3-NPH solution and 20 μl of EDC solution to 20 μl of the supernatant obtained in step ④, shake for 2 min, and place in a 50°C water bath for 30 min to obtain a gradient concentration mixed standard solution after derivatization as a sample;
[0088] ⑥, injecting the gradient concentration mixed standard solution obtained in step ⑤ into a high performance liquid chromatography-tandem mass spectrometer for detection, taking the sample concentration as the horizontal coordinate and the peak area as the vertical coordinate to construct a short-chain fatty acid standard curve;
[0089] The conditions of the HPLC are as follows:
[0090] Chromatographic column: Waters BEH C18 liquid phase column 100mm×2.1mm×1.7μm; column temperature 40℃, flow rate 30μl / min, acquisition time 10min, injection volume 5μl; mobile phase A is water; mobile phase B is acetonitrile;
[0091] Gradient elution program:
[0092]
[0093] The mass spectrometry source parameters of the tandem mass spectrometer are as follows: monitoring mode: MRM, GS1: 43 psi; GS2: 48 psi, curtain gas: 30 psi, collision gas: 7 psi, ion spray voltage: 5500 V, focusing voltage: 22 V, temperature: 233° C.;
[0094] The short-chain fatty acid standard curve is:
[0095] Acetic acid: y = 8939.40456x + 7.08221e5;
[0096] Propionic acid: y = 6.54585e4x + 4.71269e5;
[0097] Butyric acid: y = 6.80889e4x + 2.45674e5;
[0098] Valeric acid: y = 57122.89199x + 6.683e4;
[0099] Hexanoic acid: y = 4.29983e4x + 1.75965e5;
[0100] Where y is the peak area, x is the short-chain fatty acid content (μg / L);
[0101] (2) Obtaining data
[0102] 1,000 typical healthy children in Shandong area were selected for blood sampling, and the blood samples were properly stored in a -80°C refrigerator; the blood samples were then purified and derivatized according to the methods described in steps ④ to ⑤, and then injected into a high performance liquid chromatography-tandem mass spectrometer, and tested according to step ⑥. The contents of acetate, propionate, butyrate, valeric acid, and caproic acid in the blood samples were calculated based on the constructed short-chain fatty acid standard curve.
[0103] 2. Acquisition of relative abundance data of intestinal microorganisms in feces
[0104] (1) Obtain feces from 1,000 typical healthy children in Shandong Province from the same batch as the blood samples in step 1 above, and mark them one by one with the blood samples, and then use the solarbio fecal microbial DNA extraction kit to extract microbial DNA from the fecal samples;
[0105] Specifically: 100 mg of fecal sample was weighed, 500 μL of SA solution was added, placed on ice for 10 min, and centrifuged at 12000 g for 1 min;
[0106] The supernatant was discarded, and 400 μL of SB solution, 20 μL of 10 mg / mL RNase A, and 20 μL of 10 mg / mL proteinase K were added to the precipitate, vortexed for 30 s, incubated at 65 °C for 30-60 min, inverted several times, and centrifuged at 12000 g for 2 min;
[0107] The supernatant was placed in a 1.5 mL centrifuge tube, 400 μL of SC solution was added, and the tube was centrifuged at 12,000 g for 2 min. The supernatant was transferred to a filter column (the filter column was placed in a collection tube), and the tube was centrifuged at 12,000 rpm for 1 min.
[0108] Pipette the filtrate into a DNA adsorption column, let it stand at room temperature for 2 minutes, and centrifuge at 12000g for 1 minute (can be repeated once);
[0109] Discard the waste liquid in the collection tube, add 500 μL of rinse solution to the adsorption column, and centrifuge at 12000 rpm for 1 min (repeat once);
[0110] Discard the waste liquid in the collection tube, put the adsorption column back into the collection tube, and centrifuge at 12000 rpm for 1 min;
[0111] After drying the adsorption column at room temperature, place the adsorption column in a new centrifuge tube, add 100 μL of the eluent preheated at 65°C, and centrifuge at 12000 rpm for 1 min.
[0112] Add the liquid in the centrifuge tube back into the adsorption column and centrifuge at 12000 rpm for 1 min. The centrifuge tube contains the fecal microbial DNA solution.
[0113] (2) The fecal microbial DNA solution extracted in step (1) was sent to Novogene Sequencing Company for sequencing. After the sequencing results were obtained, the sequencing results were annotated with species classification using the dada2 package and the ggplot2 package in the R software to form an ASV table. The sequencing results were flattened using the vegan package. The relative abundance of species was calculated and analyzed using the MicrobiotaProcess, ggplot2, and phyloseq packages to obtain the relative abundance data of common intestinal microorganisms.
[0114] 3. Correlation analysis between relative abundance of intestinal microorganisms and content of short-chain fatty acids
[0115] (1) Based on the obtained data on the content of short-chain fatty acids in the blood and the relative abundance of intestinal microorganisms in the feces, the corrplot package, Hmisc package, and ggplot2 package in the R software were used to calculate the correlation coefficients between the abundance of Lactobacillus, Bacteroides, Bacillus, Bifidobacterium, Clostridium, and Enterobacter in the feces and the content of acetate, propionate, butyrate, valeric acid, and caproic acid in the blood. The results are shown in Table 2.
[0116] Table 2. Pearson correlation coefficient between short-chain fatty acids and intestinal microorganisms
[0117]
[0118]
[0119] (2) In the correlation coefficient table between intestinal microorganisms and short-chain fatty acids, short-chain fatty acids with strong correlation were selected and the correlation formula was calculated for each pair of intestinal microorganisms. The BestFitM package in the R software was used to analyze the optimal fitting parameter model for each pair of short-chain fatty acids and intestinal microorganism content; the Pearson correlation coefficient between each intestinal microorganism and short-chain fatty acid was calculated according to the optimal model parameters; the Pearson correlation coefficient was compared to select short-chain fatty acids and intestinal microorganisms with strong correlation (Pearson correlation coefficient>0.4); the calculation formula of the Pearson correlation coefficient is as follows:
[0120]
[0121] Among them, X i and Y i is the i-th pair of observations in the sample data, in the present invention, X is the content of short-chain fatty acids in the blood, Y is the relative abundance of microorganisms in the intestine at the genus level, and are the means of X and Y, respectively, and r is the Pearson correlation coefficient.
[0122] If there is a correlation between intestinal microorganisms and multiple short-chain fatty acids at the genus level, correlation formulas are established respectively; when determining the relative abundance of intestinal microorganisms through correlation formulas, multiple correlation formulas are used for calculation respectively, and the relative abundance of intestinal microorganisms refers to the average value of the calculation results;
[0123] (3) From the Pearson correlation coefficient, it can be seen that acetic acid is highly correlated with Bifidobacterium, propionic acid is highly correlated with Bacillus, butyric acid is highly correlated with Lactobacillus, valeric acid is highly correlated with Bacteroides, and caproic acid is highly correlated with Clostridium. The short-chain fatty acid content with high correlation and the intestinal microbial content were subjected to pairwise fitting analysis to obtain the fitting formula, as shown in Table 3.
[0124] Table 3. Fitting formulas for key intestinal microorganisms and short-chain fatty acids
[0125]
[0126]
[0127] The fitting formula is as follows:
[0128] The fitting formula for acetic acid and Bifidobacterium is: y = 0.06650x + 0.00014;
[0129] The fitting formula for propionic acid and Enterobacter is: y = 0.00103x + 0.00009;
[0130] The fitting formula of propionic acid and Bacillus is: y = 0.007055x + 0.00593;
[0131] The fitting formula for butyric acid and Lactobacillus is: y = 0.001952x + 0.00624;
[0132] The fitting formula for valeric acid and Bacteroides is: y = 0.002554x + 0.002124;
[0133] The fitting formula for hexanoic acid and Clostridium is: y = 0.02271x + 0.00009;
[0134] Among them, y is the relative abundance of intestinal microorganisms at the genus level, and x is the content of short-chain fatty acids in the blood (mg / L).
[0135] Example 2: Accuracy determination of the intestinal microorganism and short-chain fatty acid fitting formula of the present invention
[0136] In this example, the relative abundance of intestinal microorganisms determined by the correlation relationship fitting formula was compared with the relative abundance of intestinal microorganisms obtained by sequencing and 16s sequencing result analysis to determine the accuracy of the method of inferring the relative abundance of intestinal microorganisms through the blood short-chain fatty acid content using the correlation relationship and fitting formula.
[0137] 1. Randomly obtain 20 blood samples from a typical population in Shandong Province, and then process the blood samples according to the method described in Example 1. Combined with the short-chain fatty acid standard curve constructed in Example 1, determine and calculate the contents of acetic acid, propionic acid, butyric acid, valeric acid, and caproic acid in the 20 blood samples.
[0138] Then, according to the fitting formula obtained in Table 3 of Example 1, the relative abundance of Bifidobacterium, Enterobacter, Bacillus, Lactobacillus, Bacteroides and Clostridium microorganisms in the intestine was calculated using the fitting formula based on the short-chain fatty acid content in the blood sample.
[0139] 2. Obtain 20 stool samples from a typical population in Shandong Province from the same batch as the blood samples in step 1 above, and mark them one by one with the blood samples. Then, according to the method described in Example 1, obtain the relative abundance of Bifidobacterium, Enterobacter, Bacillus, Lactobacillus, Bacteroides, and Clostridium microorganisms in the stool by sequencing.
[0140] 3. The deviation between the results of the method of extracting DNA from feces to determine the relative abundance of intestinal microorganisms and the method of calculating the relative abundance of intestinal microorganisms through the content of short-chain fatty acids based on the fitting formula was calculated. The results are shown in Table 4.
[0141] Table 4. Results and standard deviations of two intestinal microbial detection methods
[0142]
[0143] As can be seen from Table 4, based on the fitting formula, the method of the present invention is used to measure the relative abundance of intestinal microorganisms at the genus level described in the table by the short-chain fatty acid content in the blood. Compared with the results of 16s sequencing, the relative error is within 35.5%, especially for Bifidobacterium and Bacteroides. The relative error is within 10%, indicating that the present invention does not require fecal sampling, and only by taking blood samples, the detection of short-chain fatty acids in the blood and the relative abundance of microorganisms in the intestine can be achieved, and the detection results for Bifidobacterium and Bacteroides are more accurate.
[0144] Example 3: Determination of fitting formulas for different microorganisms in the intestine
[0145] In this example, a correlation analysis of intestinal microorganisms at the genus level was performed based on the first batch of intestinal microbial relative abundance data obtained in Example 1.
[0146] 1. The corrplot package, Hmisc package, and ggplot2 package in R software were used to calculate the correlation coefficient between the relative abundance of the first batch of intestinal microorganisms Lactobacillus, Bacteroides, Bacillus, Bifidobacterium, Clostridium, and Enterobacter in feces and the relative abundance of the second batch of intestinal microorganisms Prevotella, Lactococcus, and Eubacterium. The results are shown in Table 5.
[0147] Table 5. Pearson correlation coefficient of relative abundance of the first batch of intestinal microorganisms and the second batch of intestinal microorganisms
[0148]
[0149]
[0150] 2. The first batch of intestinal microorganisms and the second batch of intestinal microorganisms with strong correlation were selected from the Pearson correlation coefficients of the relative abundance of different intestinal microorganisms to calculate the correlation formula in pairs, and the BestFitM package in the R software was used to analyze the optimal fitting parameter model for each pair of intestinal microorganism content; the Pearson correlation coefficient between each intestinal microorganism was calculated according to the optimal model parameters; the Pearson correlation coefficient was compared to select the intestinal microorganism with strong correlation (Pearson correlation coefficient>0.4); the calculation formula of the Pearson correlation coefficient is as follows:
[0151]
[0152] Among them, X i and Y i is the i-th pair of observations in the sample data, in the present invention, X is the first batch of intestinal microorganisms with known relative abundance, Y is the relative abundance of the second batch of intestinal microorganisms in the intestine at the genus level, and are the means of X and Y, respectively, and r is the Pearson correlation coefficient.
[0153] If there are multiple correlation relationships between the first batch of intestinal microorganisms and the second batch of intestinal microorganisms at the genus level, correlation formulas are established respectively; when determining the relative abundance of the second batch of intestinal microorganisms through the correlation formula, multiple correlation formulas are used for calculation respectively, and the relative abundance of intestinal microorganisms refers to the average value of the calculation results;
[0154] (3) From the Pearson correlation coefficient, it can be seen that Prevotella and Bifidobacterium, Lactococcus and Lactobacillus, and Eubacterium and Bifidobacterium are highly correlated. The first batch of intestinal microorganisms with high correlation and the second batch of intestinal microorganisms were subjected to pairwise fitting analysis to obtain the fitting formula, as shown in Table 6.
[0155] Table 6. Fitting formulas for the first batch of intestinal microorganisms and the second batch of intestinal microorganisms
[0156]
[0157]
[0158] The fitting formula is as follows:
[0159] The fitting formula for Prevotella and Bifidobacterium is: y = 0.62296x + 0.00001;
[0160] The fitting formula for Eubacterium and Bifidobacterium is: y = 0.83341x + 0.00003;
[0161] The fitting formula for Lactococcus and Lactobacillus is: y = 0.62296x + 0.00001;
[0162] Among them, y is the relative abundance of the second batch of intestinal microorganisms at the genus level, and x is the relative abundance of the first batch of intestinal microorganisms at the genus level.
[0163] Example 4: Accuracy determination of the intestinal microbial fitting formulas of the present invention
[0164] In this example, the relative abundance of intestinal microorganisms determined by the correlation relationship fitting formula was compared with the relative abundance of intestinal microorganisms obtained by sequencing and 16s sequencing result analysis to determine the accuracy of the method of using the correlation relationship and fitting formula to infer the relative abundance of the second batch of intestinal microorganisms from the relative abundance of the first batch of intestinal microorganisms.
[0165] 1. Randomly obtain 20 blood samples from a typical population in Shandong Province, and then process the blood samples according to the method described in Example 1. Combined with the short-chain fatty acid standard curve constructed in Example 1, determine and calculate the contents of acetic acid, propionic acid, butyric acid, valeric acid, and caproic acid in the 20 blood samples.
[0166] Then, according to the fitting formula obtained in Table 3 of Example 1, the relative abundance of the first batch of intestinal microorganisms Bifidobacterium, Enterobacter, Bacillus, Lactobacillus, Bacteroides, and Clostridium in the feces was calculated using the fitting formula based on the short-chain fatty acid content in the blood sample.
[0167] 2. Obtain 20 stool samples from a typical population in Shandong Province from the same batch as the blood samples in step 1 above, and mark them one by one with the blood samples. Then, according to the method described in Example 1, obtain the relative abundance of the second batch of intestinal microorganisms Prevotella, Eubacterium, and Lactococcus in the stool by sequencing.
[0168] 3. According to the fitting formula obtained in Table 6 in Example 3, the relative abundance of the second batch of intestinal microorganisms Prevotella, Eubacterium, and Lactococcus was calculated from the relative abundance of the first batch of intestinal microorganisms Bifidobacterium, Enterobacter, Bacillus, Lactobacillus, Bacteroides, and Clostridium microorganisms calculated in step 1.
[0169] 4. The deviation between the results of the method of extracting DNA from feces to determine the relative abundance of intestinal microorganisms and the method of calculating the relative abundance of other intestinal microorganisms based on the calculated relative abundance of intestinal microorganisms based on the fitting formula was calculated. The results are shown in Table 7.
[0170] Table 7. Results and standard deviations of two intestinal microbial detection methods
[0171]
[0172] As can be seen from Table 7, based on the fitting formula, the method of the present invention is used to measure the relative abundance of intestinal microorganisms at the genus level described in the table by the short-chain fatty acid content in the blood. Compared with the results of 16s sequencing, the relative error is within 15%, especially for Prevotella and Eubacterium. The relative error is within 10%, indicating that the present invention does not require fecal sampling, and only by taking blood samples, the detection of short-chain fatty acids in the blood and the relative abundance of microorganisms in the intestine can be achieved, and the relative abundance of other microorganisms can be calculated by the relative abundance of known microorganisms in the intestine.
Claims
1. A method for detecting intestinal microorganisms based on correlation analysis of short-chain fatty acids in blood, characterized in that: The steps include: S1: construct a standard curve of short-chain fatty acids; S2: Based on the short-chain fatty acid standard curve constructed in S1, the LC-MS / MS method was used to determine and calculate the content of short-chain fatty acids in the blood sample; S3: Based on the short-chain fatty acid content in the blood sample measured in S2, the relative abundance of the first batch of intestinal microorganisms was calculated using a fitting formula; S4: Based on the relative abundance of the first batch of intestinal microorganisms obtained in S3, the relative abundance of the second batch of intestinal microorganisms is calculated using a fitting formula.
2. The intestinal microorganism detection method based on the correlation analysis of short-chain fatty acids in blood according to claim 1, characterized in that: In S1, the short-chain fatty acids are acetic acid, propionic acid, butyric acid, valeric acid, and caproic acid.
3. The intestinal microorganism detection method based on short-chain fatty acid correlation analysis in blood according to claim 1, characterized in that: In S1, the short-chain fatty acid standard curve is: Acetic acid: y = 8939.40456x + 7.08221e5; Propionic acid: y = 6.54585e4x + 4.71269e5; Butyric acid: y = 6.80889e4x + 2.45674e5; Valeric acid: y = 57122.89199x + 6.683e4; Hexanoic acid: y = 4.29983e4x + 1.75965e5; Where y is the peak area and x is the concentration of short-chain fatty acids (μg / L).
4. The intestinal microorganism detection method based on short-chain fatty acid correlation analysis in blood according to claim 1, characterized in that: In S3, the first batch of intestinal microorganisms are Lactobacillus, Bacteroides, Bacillus, Bifidobacterium, Clostridium, and Enterobacter.
5. The intestinal microorganism detection method based on the correlation analysis of short-chain fatty acids in blood according to claim 1, characterized in that: In S3, the fitting formula is as follows: The fitting formula for acetic acid and Bifidobacterium is: y = 0.06650x + 0.00014; The fitting formula for propionic acid and Enterobacter is: y = 0.00103x + 0.00009; The fitting formula of propionic acid and Bacillus is: y = 0.007055x + 0.00593; The fitting formula for butyric acid and Lactobacillus is: y = 0.001952x + 0.00624; The fitting formula for valeric acid and Bacteroides is: y = 0.002554x + 0.002124; The fitting formula for hexanoic acid and Clostridium is: y = 0.02271x + 0.00009; Among them, y is the relative abundance of the first batch of intestinal microorganisms at the genus level, and x is the content of short-chain fatty acids in the blood (mg / L).
6. The intestinal microorganism detection method based on the correlation analysis of short-chain fatty acids in blood according to claim 1, characterized in that: In S4, the second batch of intestinal microorganisms are Prevotella, Lactococcus, and Eubacterium.
7. The intestinal microorganism detection method based on correlation analysis of short-chain fatty acids in blood according to claim 1, characterized in that: In S4, the fitting formula is as follows: The fitting formula for Prevotella and Bifidobacterium is: y = 0.62296x + 0.00001; The fitting formula for Eubacterium and Bifidobacterium is: y=0.83341x+0.00003; The fitting formula for Lactococcus and Lactobacillus is: y = 0.62296x + 0.00001; Among them, y is the relative abundance of the second batch of intestinal microorganisms at the genus level, and x is the relative abundance of the first batch of intestinal microorganisms at the genus level.
8. The intestinal microorganism detection method based on correlation analysis of short-chain fatty acids in blood according to claim 1, characterized in that: The specific steps of the intestinal microorganism detection method based on the correlation analysis of short-chain fatty acids in the blood are as follows: (1) Accurately weigh 0.001 mg of each standard of acetic acid, propionic acid, butyric acid, valeric acid, and caproic acid into a 10 ml volumetric flask, and dissolve them in 50% acetonitrile solution to prepare a mixed short-chain fatty acid standard solution with a concentration of 1 mg / L for each short-chain fatty acid; (2) adding the mixed short-chain fatty acid standard solution prepared in step (1) to 2 ml of blank plasma to obtain a mixed standard solution with gradient concentrations; the gradient concentrations are 500 μg / L, 250 μg / L, 150 μg / L, 100 μg / L, 50 μg / L, 20 μg / L, 10 μg / L, 5 μg / L, 2.5 μg / L, 1 μg / L, 0.5 μg / L, 0.25 μg / L, and 0.1 μg / L; (3) Accurately weigh 0.948 g of 3-nitrophenylhydrazine hydrochloride and 0.5751 g of 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride, and dilute to 25 ml with 50% acetonitrile aqueous solution to prepare 200 mmol / L 3-nitrophenylhydrazine hydrochloride solution (3-NPH) and 120 mmol / L 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride solution (EDC); (4) Add 0.5 ml of analytical grade acetonitrile solution to 1 ml of the mixed standard solution with gradient concentrations in step (2), centrifuge at 10,000 x g for 5 min, and collect the purified supernatant; (5) Add 20 μl of 3-nitrophenylhydrazine hydrochloride solution and 20 μl of 1-ethyl-(3-dimethylaminopropyl)carbodiimide hydrochloride solution to 20 μl of the supernatant obtained in step (4), shake for 2 min, and place in a 50°C water bath for 30 min to obtain a gradient concentration mixed standard solution after derivatization as a sample; (6) injecting the gradient concentration mixed standard solution obtained in step (5) into a high performance liquid chromatography-tandem mass spectrometer for detection, using the sample concentration as the horizontal axis and the peak area as the vertical axis to construct a short-chain fatty acid standard curve; The conditions of the HPLC are as follows: Chromatographic column: Waters BEH C18 liquid phase column 100mm×2.1mm×1.7μm; column temperature 40℃, flow rate 30μl / min, acquisition time 10min, injection volume 5μl; mobile phase A is water; mobile phase B is acetonitrile; Gradient elution program: The mass spectrometry source parameters of the tandem mass spectrometer are as follows: monitoring mode: MRM, GS1: 43 psi; GS2: 48 psi, curtain gas: 30 psi, collision gas: 7 psi, ion spray voltage: 5500 V, focusing voltage: 22 V, temperature: 233° C.; The short-chain fatty acid standard curve is: Acetic acid: y = 8939.40456x + 7.08221e5; Propionic acid: y = 6.54585e4x + 4.71269e5; Butyric acid: y = 6.80889e4x + 2.45674e5; Valeric acid: y = 57122.89199x + 6.683e4; Hexanoic acid: y = 4.29983e4x + 1.75965e5; Where y is the peak area, x is the short-chain fatty acid content (μg / L); (7) collecting blood from the test subject, purifying and derivatizing the blood according to steps (4) to (5), and injecting the blood into a high performance liquid chromatography-tandem mass spectrometer for detection, and calculating the contents of acetic acid, propionic acid, butyric acid, valeric acid, and caproic acid in the blood sample according to the short-chain fatty acid standard curve constructed in step (6); (8) Calculating the relative abundance of the first batch of intestinal microorganisms using a fitting formula based on the contents of acetic acid, propionic acid, butyric acid, valeric acid, and caproic acid determined in step (7); The fitting formula is as follows: The fitting formula for acetic acid and Bifidobacterium is: y = 0.06650x + 0.00014; The fitting formula for propionic acid and Enterobacter is: y = 0.00103x + 0.00009; The fitting formula of propionic acid and Bacillus is: y = 0.007055x + 0.00593; The fitting formula for butyric acid and Lactobacillus is: y = 0.001952x + 0.00624; The fitting formula for valeric acid and Bacteroides is: y = 0.002554x + 0.002124; The fitting formula for hexanoic acid and Clostridium is: y = 0.02271x + 0.00009; Among them, y is the relative abundance of the first batch of intestinal microorganisms at the genus level, and x is the content of short-chain fatty acids in the blood (mg / L); (9) Calculating the relative abundance of the second batch of intestinal microorganisms using a fitting formula based on the relative abundance of the first batch of intestinal microorganisms calculated in step (8); The fitting formula is as follows: The fitting formula for Prevotella and Bifidobacterium is: y = 0.62296x + 0.00001; The fitting formula for Eubacterium and Bifidobacterium is: y = 0.83341x + 0.00003; The fitting formula for Lactococcus and Lactobacillus is: y = 0.62296x + 0.00001; Among them, y is the relative abundance of the second batch of intestinal microorganisms at the genus level, and x is the relative abundance of the first batch of intestinal microorganisms at the genus level.
